|
ZNHIT2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.883000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.314000E-01 |
| Normal-vs-Stage2 |
5.885600E-01 |
| Normal-vs-Stage3 |
9.664600E-01 |
| Normal-vs-Stage4 |
4.078500E-02 |
| Stage1-vs-Stage2 |
9.547400E-01 |
| Stage1-vs-Stage3 |
4.276600E-01 |
| Stage1-vs-Stage4 |
1.877460E-03 |
| Stage2-vs-Stage3 |
5.611800E-01 |
| Stage2-vs-Stage4 |
2.078400E-02 |
| Stage3-vs-Stage4 |
3.607600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.451400E-01 |
| Normal-vs-AfricanAmerican |
2.187900E-02 |
| Normal-vs-Asian |
3.467400E-01 |
| Caucasian-vs-AfricanAmerican |
5.441100E-03 |
| Caucasian-vs-Asian |
4.391600E-01 |
| AfricanAmerican-vs-Asian |
1.215770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.780800E-01 |
| Normal-vs-Female |
3.099800E-01 |
| Male-vs-Female |
2.297800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.309200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.507400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.590000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.970400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.350600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.056200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.493600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.493400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.032100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.110990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.991400E-01 |
| Normal-vs-Grade 2 |
8.017000E-01 |
| Normal-vs-Grade 3 |
8.574000E-01 |
| Normal-vs-Grade 4 |
2.399200E-01 |
| Grade 1-vs-Grade 2 |
8.068200E-01 |
| Grade 1-vs-Grade 3 |
6.783200E-01 |
| Grade 1-vs-Grade 4 |
3.309000E-01 |
| Grade 2-vs-Grade 3 |
5.720800E-01 |
| Grade 2-vs-Grade 4 |
9.768100E-02 |
| Grade 3-vs-Grade 4 |
2.529600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.752000E-01 |
| Normal-vs-ccB subtype |
1.499820E-01 |
| ccA subtype-vs-ccB subtype |
5.703600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.260400E-01 |
| Normal-vs-N1 |
9.800800E-01 |
| N0-vs-N1 |
9.374600E-01 |
|
|
